MedTrace Logo

The Impact of FIFA 11+ on Isokinetic Muscle Strength and Balance

NCT06049628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-09-22

No results posted yet for this study

Summary

FIFA 11+ program; It consists of simple, easily remembered, and time-consuming, sport-specific exercises underlying fair play. Although the FIFA 11+ program is a well-established warm-up protocol for injury prevention among football players, the performance improvement aspect of the program is not often discussed in the literature. The study's objective is to investigate the efficacy of the FIFA 11+ program on sports performance parameters such as dynamic balance, isokinetic muscle strength performance in adolescent amateur male football players.

Conditions

  • Injury Prevention

Interventions

BEHAVIORAL

FIFA 11+ exercise program

FIFA 11+ program; It consists of simple, easily remembered, and time-consuming, sport-specific exercises underlying fair play. The F 11+ consisted of 3 parts: the first part consisted of running exercises (part 1); the second part included six exercises, which were made up of three levels of difficulty and aimed at enhancing balance, strength, muscle control, and core stability (part 2). The final and the third part covered advanced running exercises (part 3) .

BEHAVIORAL

routine program

This program consists of jogging, and stretching exercises.

Sponsors & Collaborators

  • Yeditepe University

    lead OTHER

Principal Investigators

  • büşra aydın erkılıç, MSc · Yeditepe University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-04-01
Completion
2019-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049628 on ClinicalTrials.gov